FGUP "TSENTRAL'NAYA APTEKA", Moscow

Economic indicators

Net loss (RA) of FGUP TSENTRAL'NAYA APTEKA made up 89.00 thousand RUB over 2020 compared to net profit of 267.00 thousand RUB over 2019, the company informed.

Revenue decreased in the accounting period by 23.25% to 152.67 million RUB from 198.93 million RUB in 2019; cost of goods sold decreased by 22.96% to 144.94 million RUB from 188.13 million RUB; sales profit fell 33.70 times to 20.00 thousand RUB from 674.00 thousand RUB.

Net profit (RAS) of FGUP TSENTRAL'NAYA APTEKA grew over 2019 by 11.72% to 267.00 thousand RUB from 239.00 thousand RUB over 2018, the company informed.

Revenue decreased in the accounting period by 8.82% to 198.93 million RUB from 218.18 million RUB in 2018; cost of goods sold decreased by 9.41% to 188.13 million RUB from 207.67 million RUB; sales profit went up by 14.63% to 674.00 thousand RUB from 588.00 thousand RUB.

Net profit (RAS) of FGUP TSENTRAL'NAYA APTEKA dropped in 2018 by 43.76% to 239.00 thousand RUB from 425.00 thousand RUB over the same period in 2017, the company informed.

Revenue decreased in the accounting period by 9.50% to 218.18 million RUB from 241.08 million RUB in 2017; cost of goods sold decreased by 9.39% to 207.67 million RUB from 229.19 million RUB; sales profit fell by 18.45% to 588.00 thousand RUB from 721.00 thousand RUB.

Net profit (RAS) of FGUP TSENTRAL'NAYA APTEKA dropped in 2017 by 0.93% to 425.00 thousand RUB from 429.00 thousand RUB over the same period in 2016, the company informed.

Revenue increased in the accounting period by 18.95% to 241.08 million RUB from 202.68 million RUB over 2016; cost of goods sold grew by 16.31% to 229.19 million RUB from 197.05 million RUB; sales profit made up 721.00 thousand RUB compared to sales loss of 404.00 thousand RUB.

Net profit (RAS) of FGUP TSENTRAL'NAYA APTEKA over 2014 was the same as in 2013 reaching 234.00 thousand RUB, the company informed.

Revenue remained in the accounting period at the same level and made up 217.96 million RUB compared to 217.96 million RUB 217.96 million RUB; cost of goods sold remained at the same level amounting to 209.93 million RUB compared to 209.93 million RUB; sales loss matched the previous year’s result amounting to 924.00 thousand RUB.

Net profit (RAS) of Tsentralnaya apteka Meditsinskogo obedineniya RAN dropped in 2013 by 20.68% to 234.00 thousand RUB from 295.00 thousand RUB over the same period in 2012, the company informed.

Revenue increased in the accounting period by 16.98% to 217.96 million RUB from 186.33 million RUB over 2012; cost of goods sold grew by 17.76% to 209.93 million RUB from 178.27 million RUB; sales loss decreased by 23.51% to 924.00 thousand RUB from 1.21 million RUB.

Net profit (RAS) of Centralnaya apteka Medicinskogo obedineniya RAN grew over 2012 2.44 times to 295.00 thousand RUB from 121.00 thousand RUB over 2011, the company informed.

Cost of goods sold remained at the same level amounting to 178.27 million RUB compared to 177.92 million RUB; sales loss made up 1.21 million RUB compared to sales profit of 537.00 thousand RUB.

Companies in the region

• FGUP GIPRONII DVO RAN
• GNPMP "INSERT"
• OO "YAKUTSKAYA R(T) PROFORGANIZATSIYA OPAR"
• UDMURTSKAYA RESPUBLIKANSKAYA ORGANIZATSIYA PROFSOYUZA ZHIZNEOBESPECHENIYA
• UROO PROFSOYUZA RABOTNIKOV SVYAZI RF